A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

NCT06029036 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Darolutamide+ADT

Sponsor

Peking University First Hospital

Collaborators

[object Object]
[object Object]